97827-17-3

Basic information

• Product Name: 1,3-Dioxane, 5-(iodomethyl)-2,2-dimethyl-
• CAS NO: 97827-17-3
• Molecular Formula: C7H13IO2
• Molecular Weight: 256.084
• Mol File: 97827-17-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1,3-Dioxane, 5-(iodomethyl)-2,2-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Dioxane, 5-(iodomethyl)-2,2-dimethyl-(97827-17-3)
• EPA Substance Registry System: 1,3-Dioxane, 5-(iodomethyl)-2,2-dimethyl-(97827-17-3)

Safety Data

• Hazardous Substances Data: 97827-17-3(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule of the compound.

Explanation

The chemical structure describes the arrangement of atoms in the compound, which is crucial for understanding its properties and reactivity.
3. Organic compound

Explanation

It is a compound primarily containing carbon and hydrogen atoms, which are bonded together in a specific arrangement.
4. Used in organic synthesis

Explanation

The compound serves as a building block or intermediate in the synthesis of more complex organic molecules.
5. Reagent in chemical reactions

Explanation

It is used to facilitate or drive specific chemical reactions, often acting as a catalyst or a reactant.
6. Utilized in the production of pharmaceuticals, agrochemicals, and other fine chemicals

Explanation

The compound is employed as a starting material or intermediate in the manufacturing process of various chemicals, including those used in the pharmaceutical and agricultural industries.
7. Hazardous nature

Explanation

The compound is considered hazardous due to its potential health and environmental effects, which necessitates careful handling and storage.
8. Potential health and environmental effects

Explanation

Exposure to the compound may pose risks to human health and the environment, such as toxicity, carcinogenicity, or ecotoxicity.
9. Careful handling required

Explanation

Due to its hazardous nature, it is essential to follow proper safety protocols, such as using personal protective equipment and handling the compound in a well-ventilated area or a fume hood.

Chemical structure

1,3-Dioxane ring with a methyl group and an iodomethyl group attached

Upstream product

• 20605-01-0 diethyl bis(hydroxymethyl)malonate 
• 67-64-1 acetone 
• 77-76-9 2,2-dimethoxy-propane 
• 51335-75-2 2,2-Dimethyl-1,3-dioxacyclohexane-5,5-dicarboxylic acid,diethyl ester 
• 4728-12-5 2,2-dimethyl-5-hydroxymethyl-1,3-dioxane 
• 82962-54-7 2,2-dimethyl-5-ethoxycarbonyl-1,3-dioxane 
• 133384-73-3 5-(toluenesulfonyloxymethyl)-2,2-dimethyl-1,3-dioxane 
• 131372-64-0 (2,2-dimethyl-1,3-dioxan-5-yl)methyl methanesulfonate 

Downstream Products

• 1262033-07-7 C₁₆H₂₁ClO₄ 
• 1262033-08-8 C₁₇H₂₄O₅ 
• 1262033-06-6 C₁₆H₂₁ClO₄ 
• 633278-48-5 (2,2-dimethyl-[1,3]dioxan-5-yl methyl)-phosphonic acid dimethyl ester 
• 113002-31-6 (3S)-(R_S)-3-benzyloxymethyl-3,4-dihydro-6-methyl-5-p-tolylsulfinyl-2H-pyran 
• 113002-27-0 [(S)-6-Methyl-5-((S)-toluene-4-sulfinyl)-3,4-dihydro-2H-pyran-3-yl]-methanol 
• 113002-35-0 [(R)-6-Methyl-5-((S)-toluene-4-sulfinyl)-3,4-dihydro-2H-pyran-3-yl]-methanol 
• 113002-30-5 (R)-1-Methyl-7-((S)-toluene-4-sulfinyl)-2,6-dioxa-bicyclo[2.2.2]octane 
• 113002-30-5 (S)-1-Methyl-7-((S)-toluene-4-sulfinyl)-2,6-dioxa-bicyclo[2.2.2]octane 
• 87106-39-6 (4R,8R)-1,1-Dimethoxy-4,8-dimethyl-decane 
• 108864-08-0 Toluene-4-sulfonic acid (2R,6S)-9,9-dimethoxy-2,6-dimethyl-nonyl ester 
• 113002-29-2 R_S-1-methyl-2-(2,2-dimethyl-1,2-dioxolanyl)-2-p-tolylsulfinyl-1-ethanone 
• 113476-99-6 (R_S)-1,1-bis(tert-butyldiphenylsilyloxymethyl)-7,7-bis(hydroxymethyl)-5-(p-tolyl)sulfinyl-4-heptanone 
• 113002-38-3 1-(2,2-Dimethyl-[1,3]dioxan-5-yl)-6-methyl-2-((R)-toluene-4-sulfinyl)-heptan-3-one 

Relevant articles and documents

CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME

An object of the present invention is to provide a crystal of a cyclic phosphonic acid sodium salt (2ccPA) with high purity and excellent storage stability and a method for producing the crystal. The present invention provides a crystal of a cyclic phosphonic acid sodium salt (2ccPA) represented by formula (1):

Synthetic studies on spiroketal natural products. IV. A stereoselective synthesis of (3S,5S,6R,9R,R(S))-3-benzyloxymethyl-9-hydroxymethyl-5-(p-tolyl)sulfin yl-1,7-dioxaspiro[5.5]undecane, a key intermediate for talaromycins

A dioxaspiro compound (4), a common intermediate for the synthesis of talaromycin A (1) and (-)-talaromycin B (2), was synthesized by two routes utilizing two kinds of asymmetric recognition of prochiral 1,3-diols controlled by sulfinyl chirality, that is, firstly by acid promoted diastereoselective C-O bond fission of the bicyclic acetal (7) to give the dihydropyran derivative (6), which has an S-hydroxymethyl group at the C3-position (7 → 6), and secondly by diastereoselective intramolecular Michael addition of the diol (5), in which the three chiral centers at C5, C6, C9 were constructed in one step (5 → 4).

ASYMMETRIC FUNCTIONALIZATION AT A PROCHIRAL CARBON CENTER BY THE AID OF SULFINYL CHIRALITY: A SELECTIVE FORMATION OF 6-SUBSTITUTED (3R,SS)- AND (3S,SS)-3-HYDROXYMETHYL-3,4-DIHYDRO-5-(p-TOLYL)SULFINYL-2H-PYRANS

A successful asymmetric functionalization of prochiral gem-bis(hydroxymethyl) groups has been achieved by the aid of a sulfinyl chirality.